1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Extracorporeal Cardiopulmonary Support Assist System Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Extracorporeal Cardiopulmonary Support Assist System by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Extracorporeal Cardiopulmonary Support Assist System by Country/Region, 2018, 2022 & 2029
2.2 Extracorporeal Cardiopulmonary Support Assist System Segment by Type
2.2.1 Cardiopulmonary Bypass Pump
2.2.2 Cardiopulmonary Bypass Monitoring Device
2.2.3 Cardiopulmonary Bypass Control Device
2.3 Extracorporeal Cardiopulmonary Support Assist System Sales by Type
2.3.1 Global Extracorporeal Cardiopulmonary Support Assist System Sales Market Share by Type (2018-2023)
2.3.2 Global Extracorporeal Cardiopulmonary Support Assist System Revenue and Market Share by Type (2018-2023)
2.3.3 Global Extracorporeal Cardiopulmonary Support Assist System Sale Price by Type (2018-2023)
2.4 Extracorporeal Cardiopulmonary Support Assist System Segment by Application
2.4.1 Cardiopulmonary Bypass Surgery
2.4.2 Long-term Cardiopulmonary Support
2.4.3 First Aid
2.4.4 Other
2.5 Extracorporeal Cardiopulmonary Support Assist System Sales by Application
2.5.1 Global Extracorporeal Cardiopulmonary Support Assist System Sale Market Share by Application (2018-2023)
2.5.2 Global Extracorporeal Cardiopulmonary Support Assist System Revenue and Market Share by Application (2018-2023)
2.5.3 Global Extracorporeal Cardiopulmonary Support Assist System Sale Price by Application (2018-2023)
3 Global Extracorporeal Cardiopulmonary Support Assist System by Company
3.1 Global Extracorporeal Cardiopulmonary Support Assist System Breakdown Data by Company
3.1.1 Global Extracorporeal Cardiopulmonary Support Assist System Annual Sales by Company (2018-2023)
3.1.2 Global Extracorporeal Cardiopulmonary Support Assist System Sales Market Share by Company (2018-2023)
3.2 Global Extracorporeal Cardiopulmonary Support Assist System Annual Revenue by Company (2018-2023)
3.2.1 Global Extracorporeal Cardiopulmonary Support Assist System Revenue by Company (2018-2023)
3.2.2 Global Extracorporeal Cardiopulmonary Support Assist System Revenue Market Share by Company (2018-2023)
3.3 Global Extracorporeal Cardiopulmonary Support Assist System Sale Price by Company
3.4 Key Manufacturers Extracorporeal Cardiopulmonary Support Assist System Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Extracorporeal Cardiopulmonary Support Assist System Product Location Distribution
3.4.2 Players Extracorporeal Cardiopulmonary Support Assist System Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Extracorporeal Cardiopulmonary Support Assist System by Geographic Region
4.1 World Historic Extracorporeal Cardiopulmonary Support Assist System Market Size by Geographic Region (2018-2023)
4.1.1 Global Extracorporeal Cardiopulmonary Support Assist System Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Extracorporeal Cardiopulmonary Support Assist System Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Extracorporeal Cardiopulmonary Support Assist System Market Size by Country/Region (2018-2023)
4.2.1 Global Extracorporeal Cardiopulmonary Support Assist System Annual Sales by Country/Region (2018-2023)
4.2.2 Global Extracorporeal Cardiopulmonary Support Assist System Annual Revenue by Country/Region (2018-2023)
4.3 Americas Extracorporeal Cardiopulmonary Support Assist System Sales Growth
4.4 APAC Extracorporeal Cardiopulmonary Support Assist System Sales Growth
4.5 Europe Extracorporeal Cardiopulmonary Support Assist System Sales Growth
4.6 Middle East & Africa Extracorporeal Cardiopulmonary Support Assist System Sales Growth
5 Americas
5.1 Americas Extracorporeal Cardiopulmonary Support Assist System Sales by Country
5.1.1 Americas Extracorporeal Cardiopulmonary Support Assist System Sales by Country (2018-2023)
5.1.2 Americas Extracorporeal Cardiopulmonary Support Assist System Revenue by Country (2018-2023)
5.2 Americas Extracorporeal Cardiopulmonary Support Assist System Sales by Type
5.3 Americas Extracorporeal Cardiopulmonary Support Assist System Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Extracorporeal Cardiopulmonary Support Assist System Sales by Region
6.1.1 APAC Extracorporeal Cardiopulmonary Support Assist System Sales by Region (2018-2023)
6.1.2 APAC Extracorporeal Cardiopulmonary Support Assist System Revenue by Region (2018-2023)
6.2 APAC Extracorporeal Cardiopulmonary Support Assist System Sales by Type
6.3 APAC Extracorporeal Cardiopulmonary Support Assist System Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Extracorporeal Cardiopulmonary Support Assist System by Country
7.1.1 Europe Extracorporeal Cardiopulmonary Support Assist System Sales by Country (2018-2023)
7.1.2 Europe Extracorporeal Cardiopulmonary Support Assist System Revenue by Country (2018-2023)
7.2 Europe Extracorporeal Cardiopulmonary Support Assist System Sales by Type
7.3 Europe Extracorporeal Cardiopulmonary Support Assist System Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Extracorporeal Cardiopulmonary Support Assist System by Country
8.1.1 Middle East & Africa Extracorporeal Cardiopulmonary Support Assist System Sales by Country (2018-2023)
8.1.2 Middle East & Africa Extracorporeal Cardiopulmonary Support Assist System Revenue by Country (2018-2023)
8.2 Middle East & Africa Extracorporeal Cardiopulmonary Support Assist System Sales by Type
8.3 Middle East & Africa Extracorporeal Cardiopulmonary Support Assist System Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Extracorporeal Cardiopulmonary Support Assist System
10.3 Manufacturing Process Analysis of Extracorporeal Cardiopulmonary Support Assist System
10.4 Industry Chain Structure of Extracorporeal Cardiopulmonary Support Assist System
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Extracorporeal Cardiopulmonary Support Assist System Distributors
11.3 Extracorporeal Cardiopulmonary Support Assist System Customer
12 World Forecast Review for Extracorporeal Cardiopulmonary Support Assist System by Geographic Region
12.1 Global Extracorporeal Cardiopulmonary Support Assist System Market Size Forecast by Region
12.1.1 Global Extracorporeal Cardiopulmonary Support Assist System Forecast by Region (2024-2029)
12.1.2 Global Extracorporeal Cardiopulmonary Support Assist System Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Extracorporeal Cardiopulmonary Support Assist System Forecast by Type
12.7 Global Extracorporeal Cardiopulmonary Support Assist System Forecast by Application
13 Key Players Analysis
13.1 Medtronic
13.1.1 Medtronic Company Information
13.1.2 Medtronic Extracorporeal Cardiopulmonary Support Assist System Product Portfolios and Specifications
13.1.3 Medtronic Extracorporeal Cardiopulmonary Support Assist System Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Medtronic Main Business Overview
13.1.5 Medtronic Latest Developments
13.2 Getinge (Maquet)
13.2.1 Getinge (Maquet) Company Information
13.2.2 Getinge (Maquet) Extracorporeal Cardiopulmonary Support Assist System Product Portfolios and Specifications
13.2.3 Getinge (Maquet) Extracorporeal Cardiopulmonary Support Assist System Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Getinge (Maquet) Main Business Overview
13.2.5 Getinge (Maquet) Latest Developments
13.3 LivaNova (Sorin)
13.3.1 LivaNova (Sorin) Company Information
13.3.2 LivaNova (Sorin) Extracorporeal Cardiopulmonary Support Assist System Product Portfolios and Specifications
13.3.3 LivaNova (Sorin) Extracorporeal Cardiopulmonary Support Assist System Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 LivaNova (Sorin) Main Business Overview
13.3.5 LivaNova (Sorin) Latest Developments
13.4 Terumo
13.4.1 Terumo Company Information
13.4.2 Terumo Extracorporeal Cardiopulmonary Support Assist System Product Portfolios and Specifications
13.4.3 Terumo Extracorporeal Cardiopulmonary Support Assist System Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Terumo Main Business Overview
13.4.5 Terumo Latest Developments
13.5 Fresenius Medical Care
13.5.1 Fresenius Medical Care Company Information
13.5.2 Fresenius Medical Care Extracorporeal Cardiopulmonary Support Assist System Product Portfolios and Specifications
13.5.3 Fresenius Medical Care Extracorporeal Cardiopulmonary Support Assist System Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Fresenius Medical Care Main Business Overview
13.5.5 Fresenius Medical Care Latest Developments
13.6 Beijing Medos AT Biotechnology Co., Ltd.
13.6.1 Beijing Medos AT Biotechnology Co., Ltd. Company Information
13.6.2 Beijing Medos AT Biotechnology Co., Ltd. Extracorporeal Cardiopulmonary Support Assist System Product Portfolios and Specifications
13.6.3 Beijing Medos AT Biotechnology Co., Ltd. Extracorporeal Cardiopulmonary Support Assist System Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Beijing Medos AT Biotechnology Co., Ltd. Main Business Overview
13.6.5 Beijing Medos AT Biotechnology Co., Ltd. Latest Developments
14 Research Findings and Conclusion
※参考情報 体外式心肺補助支援システム(Extracorporeal Cardiopulmonary Support Assist System)は、心肺機能が不全の状態にある患者に対して、人工的に血液を循環させ、酸素化することを目的とした医療機器です。このシステムは、心肺の機能を一時的に補助または代替するために使用され、特に重篤な心不全や呼吸不全の患者において生命維持のために重要な役割を果たします。 まず、体外式心肺補助支援システムの基本的な概念としては、体外循環により血液を循環させる仕組みが挙げられます。このシステムは一般的に、人工心肺装置と呼ばれる装置を用いており、これによって血液を体外に取り出し、適切な酸素を供給した後に再び患者の体内に戻します。これにより、心臓や肺が機能不全に陥っている場合でも、必要な酸素を届けることが可能となります。 このシステムの特徴の一つは、心臓や肺の機能を一時的に補い、患者の状態を安定させることができる点です。多くの場合、急性の病態に対して迅速に対応できるため、一時的な治療として有効です。また、従来の心肺機能が回復するまでの間、血液の循環と酸素化を維持することで、生命を救う可能性を高めます。 体外式心肺補助支援システムの種類については、主に二つに分類されます。ひとつはECMO(Extracorporeal Membrane Oxygenation)です。この技術は、膜型酸素化装置を用いて血液を酸素化し、二酸化炭素を除去します。ECMOは、心臓や肺の機能が著しく低下した場合に用いられ、心臓と肺の両方に対してサポートを提供することができます。もう一つは、心臓補助装置(VAD, Ventricular Assist Device)です。これは、心臓のポンプ機能を補うために特化した装置で、主に心不全の患者に対して用いられます。 用途としては、体外式心肺補助支援システムは様々な状況で使用されます。急性呼吸窮迫症候群(ARDS)、心筋梗塞後や心臓手術後の心不全、重篤な肺疾患やショック状態などで、患者の生命維持のために必要とされることが多いです。特に、ECMOは小児から成人に至るまで幅広い対象に使用されるため、救急医療の現場でも重要な役割を果たしています。 関連技術についても触れておく必要があります。体外式心肺補助支援システムは、近年の医療技術の進歩によってさらなる向上を遂げており、特にモニタリング技術やセンサー技術の進化が顕著です。これにより、患者の状態をリアルタイムで把握し、迅速な対応が可能となっています。また、バイオマテリアルの開発や、自己抗凝固性素材を用いた装置の進歩により、血栓症のリスクを低減し、長期使用を可能にする取り組みも進められています。 これまでに述べたように、体外式心肺補助支援システムは、心肺機能不全の患者に対して生命維持のための重要な手段であり、多岐にわたる用途と技術の進歩があります。そのため、医療現場では、効果的な利用方法や新たな技術の研究が続けられており、今後もますます重要な役割を果たすことが期待されています。患者の安全と治療の向上を目指した研究開発が進む中、このシステムのさらなる発展と効果的な運用が求められています。 |
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/